Treatment Outcomes in Bile Duct Stones
Treatment Outcomes in Bile Duct Stones
This registry is to evaluate the procedural and clinical outcomes in patients undergoing
 endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.
Gallstone diseases are common, affecting 20 million patients in the United States with
 associated costs of over US $6 billion. Common bile duct (CBD) stones in turn occur in 15-20%
 patients with gallstone disease and require treatment due to risk of infection and
 pancreatitis. Endoscopic treatment via endoscopic retrograde cholangiopancreatography (ERCP)
 is the treatment modality of choice in CBD stones. The most simple treatment techniques
 include biliary sphincterotomy and stone extraction via the use of standard devices such as a
 stone retrieval balloons or stone retrieval baskets. However, patients with difficult bile
 duct stones require advanced maneuvers namely mechanical lithotripsy, large balloon
 sphincteroplasty (LBS) of the major duodenal papilla and single operator
 cholangioscopy-guided lithotripsy (SOC-LL).

 Currently, there are no standardized treatment approaches in the management of CBD stones,
 especially in the management of difficult CBD stones. Therefore, ERCP in patients with
 difficult CBD stones can be inefficient and prolonged with use of multiple devices and
 techniques. In an effort to standardize the management of bile duct stones, we have devised
 an algorithm for the treatment of bile duct stones using current standard of care methods,
 taking into account the size of bile duct stones, size of bile duct and availability of
 endoscopic expertise. The objective of this registry is to evaluate the procedural and
 clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when
 utilizing an algorithmic management approach.
Inclusion Criteria:

 1. All patients with confirmed or suspected bile duct stones undergoing endoscopic
 therapy for treatment of bile duct stones

 2. Patients 18 years or over

 Exclusion Criteria:

 1. Patients not undergoing endoscopic therapy for bile duct stones

 2. Patients < 18 years of age